310 Participants Needed

Intercostal Plane Block for Post Cardiac Surgery Pain

(EPOCH Trial)

AQ
AA
Overseen ByAhmad Alli, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, if you are using opioids or narcotics regularly, you may not be eligible to participate.

What data supports the effectiveness of the treatment Intermittent Superficial Parasternal Intercostal Plane Block, Naropin for post-cardiac surgery pain?

Research suggests that parasternal intercostal nerve blocks, like the superficial parasternal intercostal plane block, can help reduce pain and the need for opioids after cardiac surgery. However, the results vary due to differences in how the procedure is done, and more standardized studies are needed to confirm these benefits.12345

Is the intercostal plane block safe for humans?

The intercostal plane block, used for pain management after cardiac surgery, has been shown to reduce the need for opioids and their side effects, suggesting it is generally safe. However, differences in how the procedure is done can affect outcomes, so standardizing the technique is important for safety.12345

How does the intercostal plane block treatment differ from other treatments for post-cardiac surgery pain?

The intercostal plane block treatment is unique because it involves injecting a local anesthetic into specific intercostal spaces under ultrasound guidance to provide pain relief after cardiac surgery. This method aims to reduce the need for opioids and their side effects, offering a potentially more favorable pain management option compared to traditional systemic pain medications.12346

What is the purpose of this trial?

The goal of this clinical trial is to assess whether the use of intermittent superficial parasternal intercostal plane blocks reduces opioid usage in patients undergoing cardiac surgery with median sternotomy.Participants randomized to the intervention group will receive the blocks with 0.2% ropivacaine administered via catheters placed in the superficial parasternal intercostal plane bilaterally under ultrasound guidance. Researchers will compare this group with a control group given 0.9% saline through similarly placed catheters. The primary outcome will be cumulative postoperative opioid use (measured as Milligram Morphine Equivalent (MME)) up to 72 hours following catheter insertion.

Research Team

AA

Ahmad Alli, MD

Principal Investigator

Unity Health Toronto

Eligibility Criteria

This trial is for adults having heart surgery through a cut down the middle of their chest (median sternotomy). It's not for those who've had this type of surgery before, are in unstable condition, weigh less than 50kg, are pregnant or nursing, use opioids long-term or have chronic pain disorders. People with allergies to certain anesthetics or unable to follow the study rules can't join either.

Inclusion Criteria

I am an adult scheduled for heart surgery through a chest bone cut.

Exclusion Criteria

I weigh less than 50kg.
You are allergic to certain types of anesthesia or any part of the study treatment.
I have had heart surgery either by reopening the chest or through less invasive methods.
See 8 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive intermittent superficial parasternal intercostal plane blocks with either 0.2% ropivacaine or 0.9% saline

72 hours
Daily monitoring for 3 days

Follow-up

Participants are monitored for safety and effectiveness after treatment, including pain assessment and opioid use

3 months
Regular follow-up visits

Post-operative Recovery

Assessment of quality of recovery using Quality of Recovery-15 Scale

Post-operative day 4-7

Treatment Details

Interventions

  • Intermittent Superficial Parasternal Intercostal Plane Block
Trial Overview The trial tests if using intermittent superficial parasternal intercostal plane blocks with ropivacaine reduces opioid need after cardiac surgery compared to placebo (saline). Participants will be randomly assigned to receive either the real block or a sham procedure and monitored for opioid use up to 72 hours post-surgery.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: 0.2% ropivacaineExperimental Treatment1 Intervention
Intermittent superficial parasternal intercostal plane block via ultrasound-guided catheter placement. Initial bolus dosing of 20 milliliter (mL) of 0.2% ropivacaine per side at the time of catheter placement, followed by intermittent boluses of 10 mL 0.2% ropivacaine per side.
Group II: 0.9% salinePlacebo Group1 Intervention
Intermitted superficial parasternal intercostal plane block via ultrasound-guided catheter placement. Initial bolus of 20 mL of 0.9% saline per side at the time of catheter placement, followed by intermitted boluses of 10 ml of 0.9% saline per side.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Unity Health Toronto

Lead Sponsor

Trials
572
Recruited
470,000+

Findings from Research

Parasternal intercostal nerve blocks can effectively reduce opioid consumption and improve pain management in patients undergoing cardiac surgery, as supported by 10 randomized trials and observational studies.
Standardization of the technique for performing these blocks is crucial, as variations in methods may significantly affect clinical outcomes, highlighting the need for consistent protocols in Enhanced Recovery After Surgery programs.
Parasternal Intercostal Nerve Blocks in Patients Undergoing Cardiac Surgery: Evidence Update and Technical Considerations.Schiavoni, L., Nenna, A., Cardetta, F., et al.[2023]
The deep parasternal intercostal plane block provides greater spread of analgesia compared to the superficial block, covering more parasternal interspaces, which could enhance pain management for surgeries like breast and cardiac procedures.
However, the deep block is closer to the internal mammary artery, raising safety concerns about potential arterial injury, suggesting it should be considered an advanced technique requiring careful application.
Superficial versus deep parasternal intercostal plane blocks: cadaveric evaluation of injectate spread.Douglas, RN., Kattil, P., Lachman, N., et al.[2023]
Both the superficial parasternal intercostal plane block (SPIP) and deep parasternal intercostal plane block (DPIP) provide effective postoperative pain management for patients undergoing median sternotomy, significantly reducing the need for opioids compared to traditional morphine use.
Patients receiving SPIP and DPIP experienced lower consumption of antiemetic medication (metoclopramide) compared to those on morphine, indicating a potential benefit in reducing side effects associated with opioid use.
Which ultrasound-guided parasternal intercostal nerve block for post-sternotomy pain? Results from a prospective observational study.Toscano, A., Capuano, P., Perrucci, C., et al.[2023]

References

Parasternal Intercostal Nerve Blocks in Patients Undergoing Cardiac Surgery: Evidence Update and Technical Considerations. [2023]
Superficial versus deep parasternal intercostal plane blocks: cadaveric evaluation of injectate spread. [2023]
Which ultrasound-guided parasternal intercostal nerve block for post-sternotomy pain? Results from a prospective observational study. [2023]
Deep Parasternal Intercostal Plane Block for Postoperative Analgesia After Sternotomy for Cardiac Surgery-A Retrospective Cohort Study. [2023]
Ultrasound-Guided Pecto-Intercostal Fascial Block for Postoperative Pain Management in Cardiac Surgery: A Prospective, Randomized, Placebo-Controlled Trial. [2021]
Evaluation of rhomboid intercostal and subserratus plane block under direct vision for postoperative analgesia in thoracic surgeries: a prospective, randomized controlled trial. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security